ARCHIVES

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

In Brief: Training Act Requires 75% Fr Institutional Grants, Rest For Individuals Fellowships

September 27, 1974

EORTC Screening, Pharmacology Group Focuses On CNU

January 2, 1987

Spending Bill Expected At White House Any Day Now; NIH Awaits 15% Increase.

October 27, 2000

MET Inhibitor Improved Time To Progression by 56 Percent

June 29, 2012

Goodfellow To Lead Gynecologic Oncology Research Team At Ohio State University

January 11, 2013

Clinical Sciences Director Liu To Head Singapore Program.

January 12, 2001